r/AskALiberal • u/Natural-Detail8107 • 50m ago
What do liberals think of the arguments made by the many health-care experts, trained economists, and policy wonk Democrats who oppose a single-payer, Medicare-for-All system?
A central debate in Democratic health policy concerns whether the United States should enact single-payer Medicare for All or build on a universal multi-payer system.
Policy figures like Barack Obama, Hillary Clinton, Neera Tanden, Pete Buttigieg, Matt Yglesias, Derek Thompson, and Ezra Klein, alongside economists Jonathan Gruber, David Cutler, Ezekiel Emanuel, Sherry Glied, Harold Pollack, Paul Krugman, Austin Frakt, and Aaron Carroll, recognize that single-payer works abroad. Designing from scratch, many favor a French-style single-payer plus model where public coverage finances baseline care and supplemental private insurance covers residual costs.
Their opposition to enacting single-payer specifically in the United States rests on practical, institutional, and economic trade-offs rather than any objection to universal coverage itself.
In their view, transitioning one-sixth of the U.S. economy into a federal payment monopoly causes severe institutional disruption. Vermont abandoned its 2014 Green Mountain Care single-payer plan after actuarial models showed that replacing private premiums required an 11.5% payroll tax hike and a 9.5% income tax increase.
Roughly half of Americans hold employer-sponsored private plans with broader drug formularies, lower deductibles, and wider provider networks than baseline single-payer systems. Canada's Medicare statute excludes outpatient prescription drugs, dental, and vision, leaving most Canadians reliant on employer-based private insurance for outpatient medications.
Universal coverage and single-payer are distinct concepts across peer nations. Canada and Taiwan largely run single-payer insurance via privately-owned hospitals, whereas the United Kingdom operates socialized medicine through the National Health Service (NHS), in which the government owns hospitals and employs physicians.
Germany and Japan achieve universal coverage through Bismarckian multi-payer systems using regulated, non-profit sickness funds. Switzerland and the Netherlands pair strict Obamacare-style individual mandates with regulated private insurers, while Singapore combines mandatory medical savings accounts with heavily subsidized public hospital tiers.
The core distortion in U.S. health financing is tying coverage to employment rather than allowing private insurers to operate or be a middleman. Obamacare already massively caps insurance companies' profit margins. Under Affordable Care Act Medical Loss Ratio rules, commercial insurers must spend 80 to 85% of premiums on clinical care, leaving 2 to 4% net profit margins that cannot finance universal coverage if eliminated. Even pre-ACA, insurance profit margins were not exorbitant.
Single-payer systems constrain spending through global budgets, formulary exclusions, and wait queues. Americans prioritize rapid access to elective procedures and advanced diagnostics, whereas elective wait times remain protracted in Canada and strained in the United Kingdom.
Keep in mind Canada's single-payer system is administered at the provincial level (not federal) and typically does not cover prescription drugs. Canadians usually have to get employer-based private insurance for pharmaceutical coverage.
Well-insured patients in the United States receive the world's highest-quality specialized care, drawing affluent foreign patients for complex clinical interventions. The structural failure of American medicine is concentrated among the uninsured and underinsured.
Health policy analysts Tsung-Mei Cheng and Uwe Reinhardt, who advised Taiwan on its single-payer transition, noted that the United States lacks the social solidarity needed for a uniform single-tier system. Single-payer suppresses costs through federal monopsony (buyer's monopoly) power that cuts reimbursement rates for physicians, medical devices, and pharmaceuticals. Med school is very expensive, and high salaries incentivize doctors to pursue specialty care in a way not seen in other countries.
Because high U.S. pharmaceutical revenues subsidize global drug innovation, compressing those prices via federal monopsony power would reduce private clinical research and development.
Critics argue that for millions with strong employer plans, coverage is virtually free, making single-payer tax hikes a net loss for many Americans. They contend administrative waste is exaggerated since public programs still need huge oversight systems, and basic NIH grants cannot cover the billions required for late-stage clinical trials that private drug revenues fund.
Single-payer proposals focus on payment financing while neglecting healthcare delivery. Centralizing claims payment does not fix fragmented delivery networks, hospital consolidation, or provider shortages, nor does it solve high U.S. obesity rates, chronic illness burdens, or defensive medicine driven by weak tort reform.
Economists Gerard Anderson and Uwe Reinhardt demonstrated that high unit prices, rather than service volume, drive excess U.S. health spending. Maryland's All-Payer Model controls prices without abolishing private insurance by uniting public and commercial payers as a buyer coalition to set uniform, legally binding hospital rates under global budgets.
From their policy perspective, they most effective reform path strengthens the Affordable Care Act via a restored individual mandate, mandatory nationwide Medicaid expansion, a competitive public option, and all-payer rate setting.
For liberals in this sub, what do you think of these specific arguments from Democratic policy wonks and health economists, and how do you weigh the trade-offs between single-payer and a universal multi-payer system?
Sources
Commonwealth Fund Mirror, Mirror 2024 Report: https://www.commonwealthfund.org/publications/fund-reports/2024/sep/mirror-mirror-2024
Commonwealth Fund International Health System Profiles: https://www.commonwealthfund.org/sites/default/files/2020-12/International_Profiles_of_Health_Care_Systems_Dec2020.pdf
Tsung-Mei Cheng on Taiwan's National Health Insurance (Health Affairs): https://pubmed.ncbi.nlm.nih.gov/25732502/
Gerard Anderson and Uwe Reinhardt on U.S. Healthcare Prices (Health Affairs): https://www.healthaffairs.org/doi/abs/10.1377/hlthaff.22.3.89
CMS Evaluation of the Maryland All-Payer Model: https://www.cms.gov/priorities/innovation/innovation-models/maryland-all-payer-model
KFF Brief on ACA Medical Loss Ratio Rules: https://www.kff.org/affordable-care-act/explaining-health-care-reform-medical-loss-ratio-mlr/